Chinese pharmaceutical firms are plunging as a drug safety scandal spills over to become a sector-wide trust crisis.

Authorities found Changsheng Biotechnology’s subsidiary produced substandard vaccines and forged production data. Its shares have been suspended from trading.

614 views